A protective role of IL-37 during the development of gastric cancer has been demonstrated, where the processed form of IL-37 binds to SMAD-3, relocates to the nucleus, and hinders the transcription of various pro-inflammatory genes. The gene discussed is IL37; the disease is gastric cancer.